Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Mutat Res ; 746(1): 1-6, 2012 Jul 04.
Article in English | MEDLINE | ID: mdl-22464985

ABSTRACT

New compounds with potential antitumour activity were synthesised by combining nitrogen mustard with the steroidal skeleton, in an effort to improve specificity and at the same time reduce systemic toxicity. The steroidal part is aimed to serve as a biological platform enabling the alkylating moiety to approach its site of action by altering its physicochemical properties. The purpose of the present investigation was to evaluate these compounds for anti-neoplastic activity. The compounds tested have as alkylators either para-NN-bis(2-chloroethyl)-aminophenyl-butyrate (CHL) or para-N,N-bis(2-chloroethyl)-aminophenyl-acetate (PHE) esterified with a differently modified steroidal nucleus. The eight newly synthesised compounds were compared on a molar basis with respect to their ability to induce sister chromatid exchanges (SCEs) and to modify proliferation rate indices (PRI) in lymphocytic leukaemia P388 cells in mice in vivo. The life span of BDF1 mice inoculated with P388 leukaemia cells was also estimated (anti-leukaemic activity). The compounds that were effective in inducing cytogenetic effects in lymphocytic leukaemia cells in vivo were also effective in inducing antineoplastic effects in BDF1 mice inoculated with P388 leukaemia cells. These results suggest that the in vivo cytogenetic effects in conjunction with the antineoplastic activity of modified steroidal alkylators depend on the configuration of the whole molecule and on the appropriate combination of the alkylator with the steroidal molecule: a pronounced cytogenetic and anti-neoplastic action was demonstrated by the compounds that contain either PHE or CHL as alkylators and are esterified with either a steroidal nucleus that carries a cholesten group in the 17 position of the D-ring, or with a steroidal nucleus having an exocyclic NHCO-group in the D-ring. In contrast, a ketone group or an NHCO-group in the D-ring inserted endocyclically in the steroidal nucleus esterified with either CHL or PHE failed to induce cytogenetic or anti-neoplastic effects.


Subject(s)
Alkylating Agents/therapeutic use , Antineoplastic Agents, Alkylating/therapeutic use , Antineoplastic Agents/therapeutic use , Leukemia P388/drug therapy , Animals , Antineoplastic Agents/chemistry , Cell Proliferation/drug effects , Drug Screening Assays, Antitumor , Leukemia P388/genetics , Mice , Nitrogen Mustard Compounds/chemistry , Sister Chromatid Exchange/drug effects , Steroids
2.
Chemotherapy ; 53(2): 118-26, 2007.
Article in English | MEDLINE | ID: mdl-17308378

ABSTRACT

Combination chemotherapy is widely and routinely used for most cancer patients. The main objective of this study is an effort to develop new anticancer drugs and procedures with enhanced antitumor activity and reduced toxicity. This study was designed to determine the antileukemic and cytogenetic activity of five mixtures of three specific steroidal esters of aromatic nitrogen mustards in different proportions. This is the next step of two previous studies where the combination of two such esteric analogues was investigated with promising results. All of the five mixtures used proved active against leukemia P388 and in the induction of sister chromatid exchanges, indicating that the combination of the same class of compounds can be successful, especially when a highly potent agent is combined with another less active but probably mechanistically supplementary one. These results can be used in future experiments in order to further scout the specific role of the steroidal part of these molecules in the antileukemic potency of them.


Subject(s)
Androstanes/pharmacology , Antineoplastic Agents/pharmacology , Azasteroids/pharmacology , Leukemia P388/drug therapy , Nitrogen Mustard Compounds/pharmacology , Animals , Cell Proliferation/drug effects , Cells, Cultured , Drug Synergism , Female , Humans , Lethal Dose 50 , Lymphocytes/drug effects , Male , Mice , Mice, Inbred BALB C , Mice, Inbred DBA , Sister Chromatid Exchange , Xenograft Model Antitumor Assays
3.
Med Chem ; 2(6): 569-76, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17105438

ABSTRACT

Recent studies have indicated that minor functional changes on the steroidal part of complex molecules, comprising of an alkylating moiety and a steroidal congener, lead to compounds with enhanced biological activity. The observed induction of the genotoxic, cytotoxic and antileukemic effects suggest a determinative role of the steroidal congener on the mechanism of action. In order to further elucidate the structural requirements responsible for this, we designed and synthesized a new modified steroid, carrying a 17beta-acetamide substituent and a B lactamic ring, and studied the ability of its esters with three potent nitrogen mustards to induce sister chromatid exchange (SCEs) and to inhibit cell proliferation in normal human lymphocytes in vitro. The role of the steroidal skeleton was clearly stated by the results of the in vitro evaluation of the final compounds, as all three derivatives proved better inducers of SCE (58-102 SCE/cell) and cell division delays (1.18-1.25 PRI) than the simple nitrogen mustards (24-38 SCE/cell and 1.51-1.62 PRI). Obviously, the steroidal module enhances the formation of DNA adducts that cannot be repaired by excision repair enzymes probably through the induction of the interaction of these complex compounds with different base sequences or by disabling the repair mechanisms through the blockage of the enzymes responsible for excision repair. On the other hand, it seems that these compounds also act through a parallel site of action responsible for cell death when their primary binding site becomes saturated, as in higher concentrations two of the derivatives tested showed enhanced cytotoxicity while their ability to induce SCE stabilized.


Subject(s)
Drug Design , Esters/chemistry , Steroids/chemistry , Steroids/pharmacology , Alkylation , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Cell Death , Cell Proliferation/drug effects , Cells, Cultured , DNA Adducts , DNA Repair , Esters/chemical synthesis , Esters/pharmacology , Humans , Lymphocytes/drug effects , Mechlorethamine/pharmacology , Mutagens/chemical synthesis , Mutagens/chemistry , Mutagens/pharmacology , Sister Chromatid Exchange/drug effects , Steroids/chemical synthesis , Structure-Activity Relationship
4.
Mini Rev Med Chem ; 3(6): 557-67, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12871158

ABSTRACT

7-keto-Delta(5)-steroids have been suggested for the treatment of several diseases. Their significant biological profile resulted in the development of a great number of methods and reagents for the allylic oxidation of Delta(5)-steroids. These methods and the biological evaluation of the main oxidized Delta(5)-steroids are summarized.


Subject(s)
Ketosteroids/chemical synthesis , Ketosteroids/metabolism , Cholesterol/chemical synthesis , Cholesterol/chemistry , Cholesterol/metabolism , Chromium/chemistry , Dehydroepiandrosterone/chemical synthesis , Dehydroepiandrosterone/chemistry , Dehydroepiandrosterone/metabolism , Humans , Ketosteroids/chemistry , Oxidation-Reduction , Oxygen/chemistry , tert-Butylhydroperoxide/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL